ENTRY       D03297                      Drug
NAME        Mecasermin (USAN/INN);
            Mecasermin (genetical recombination) (JAN);
            Increlex (TN);
            Myotrophin (TN)
PRODUCT     INCRELEX (Ipsen Biopharmaceuticals)
FORMULA     C331H512N94O101S7
EXACT_MASS  7643.5862
MOL_WEIGHT  7648.6312
SEQUENCE    GPETLCGAEL VDALQFVCGD RGFYFNKPTG YGSSSRRAPQ TGIVDECCFR SCDLRRLEMY
            CAPLKPAKSA
            (Disulfide bridge: 6-48, 18-61, 47-52)
  TYPE      Peptide
REMARK      Therapeutic category: 2499
            ATC code: H01AC03
            Chemical structure group: DG01359
            Product (DG01359): D03297<JP/US>
EFFICACY    Antidiabetic, Insulin-like growth factor receptor agonist
  DISEASE   Primary IGF-1 deficiency [DS:H02040]
COMMENT     Recombinant Human Insulin-like growth factor I [HSA:3479] [KO:K05459]
            Treatment of amyotrophic lateral sclerosis, Treatment of diabetes mellitus (types I and types II), Treatment of growth hormone insensitivity (GHIS)
TARGET      IGF1R (CD221) [HSA:3480] [KO:K05087]
            GHR [HSA:2690] [KO:K05080]
  PATHWAY   hsa04151(2690+3480)  PI3K-Akt signaling pathway
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
              H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
               H01A ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
                H01AC Somatropin and somatropin agonists
                 H01AC03 Mecasermin
                  D03297  Mecasermin (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
              Mecasermin
               D03297  Mecasermin (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2499  Others
                 D03297  Mecasermin (USAN/INN); Mecasermin (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               INSR family
                IGF1R (CD221)
                 D03297  Mecasermin (USAN/INN) &lt;JP/US&gt;
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                GHR
                 D03297  Mecasermin (USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D03297
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03297
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D03297
DBLINKS     CAS: 68562-41-4
            PubChem: 17397448
            NIKKAJI: J2.215.442G
///
